semaglutide black box Family Blames Popular Weight Loss Drug for Man's Suicide, Seeks Warning Ozempic and Wegovy Users Had
Description
Semaglutide was originally developed to treat type 2 diabetes, with clinical trials showing patients reaching 1.0 mg weekly as a standard therapeutic dose for metabolic control
Some individuals report increased queasiness when injecting immediately after eating a large meal, likely because the medication further slows stomach emptying of food already present
Support Community Join our caring Jacksonville community of successful weight loss patients who support and motivate each other towards lasting health
doi: 10.1053/j.gastro.2012.05.008
